The Multidisciplinary Association for Psychedelic Studies (MAPS) is pivoting its focus to state-level initiatives following ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

Assessing the ability of psychedelics to enhance evidence-based treatments like PE and MPE, which have a large base of ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

Within a week of the FDA's decision, Lykos announced it was cutting its staff by 75% and that Rick Doblin, PhD, the founder ...

Privately-owned Lykos Therapeutics continues to reel from its devastating rejection by the Food and Drug Administration (FDA) ...

Lykos Therapeutics CEO Amy Emerson steps down following the FDA's rejection of the company's MDMA-based PTSD therapy.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Psychedelics were high on the agenda for an official panel and public commenters, including the fallout from the FDA's MDMA ...

In April, HHS’ Office for Civil Rights issued a final rule that said health providers can’t discriminate against patients by ...